23-Sep-16 Merck’s immunotherapy cancer drug Keytruda is finding its way into China as the first imported drug approved for use under a pilot program on the resort island of Hainan intended to boost medical tourism. The zone in Boao is likely to attract patients who would otherwise travel to Hong Kong or Macau for drugs yet to be approved in China. [image: Anthony Wallace / AFP / Getty Images]

21-Feb-16 Iran and Russia have inked three memoranda of understanding to boost medical cooperation, ranging from exchanging knowledge and technology to importing and exporting medications. Iranian pharma companies are eager to export their products to Russia and Russian officials are optimistic. [image: Tehran Times]

17-Feb-16 Bausch + Lomb has entered a partnership in India with global technology company Bosch. This cooperation brings together leading providers of eye care solutions and technology in India, to market diagnostic devices in the ophthalmic segment. Bausch + Lomb will market Bosch's Fundus retina camera, which can detect conditions such as cataract at an early stage. [image: Bausch & Lomb]

15-Feb-16 China plans to consolidate its huge and fragmented drug market and will support a greater role for traditional Chinese medicines (TCM). China is a major lure for drug firms targeting growth driven by rising incomes and a fast-ageing population. Beijing is keen, however, for local firms to take a larger slice of the market. [image: Reuters / Aly Song]

08-Dec-15 China's implementation of healthcare reforms, changing the approval process for new medical devices and favoring local manufacturers will restrain growth for US medical manufacturers, says Moody's. China's healthcare reforms will be particularly credit negative for companies that make complex devices, such as Medtronic, Boston Scientific and St Jude. [image: Shannon Stapleton / Reuters]